Enstilar 01
Chemical structure of calcipotriene, an active ingredient in ENSTILAR topical aerosol foam.*
Enstilar Aerosol, Foam
Product Images NDC 50222-302
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Enstilar (NDC 50222-302). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Leo Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Enstilar 02
Chemical structure of the active ingredient betamethasone dipropionate in ENSTILAR aerosol foam topical medication by LEO Pharma Inc.*
Enstilar 03
A line graph comparing the percentage of subjects over weeks after randomization between two treatment groups: Enstilar Foam Twice Weekly and Vehicle Foam Twice Weekly. The y-axis represents the percentage of subjects, and the x-axis displays time in weeks from 0 to 52. The solid line shows Enstilar Foam group data, and the dotted line shows Vehicle Foam group data.*
Enstilar 04
An instructional illustration showing a hand holding and shaking an aerosol canister with repeated motion lines indicating shaking. The aerosol can is plain with no visible labeling or branding.*
Enstilar 05
An instructional illustration showing a hand holding and aiming an aerosol foam canister approximately 1.5 inches away from the opposite forearm, demonstrating the correct distance for spraying the foam.*
Enstilar 06
An illustration showing a person applying a topical medication to their leg using an aerosol foam dispenser. The image demonstrates proper hand positioning for application.*
Enstilar 07
An instructional illustration showing hands applying topical foam to an arm. The image visually demonstrates the method of spreading foam medication onto the skin, suitable for products like ENSTILAR aerosol foam for topical use.*
Enstilar 08
Packaging label for Enstilar aerosol foam containing calcipotriene and betamethasone dipropionate 0.005%/0.064%, topical use only. The 60 gram carton displays directions to shake before use and warnings against oral, ophthalmic, or intravaginal use. Manufacturer is LEO Laboratories Ltd., distributed by LEO Pharma Inc. Includes usage cautions and storage instructions.*
Enstilar 09
The packaging label for Enstilar foam, containing calcipotriene and betamethasone dipropionate, topical aerosol with strengths of 0.005% and 0.064%. The label includes directions to shake before use and states it is for topical use only, not for oral, ophthalmic, or intravaginal use. Net weight is 120 grams (2 cans of 60 grams). Manufactured by LEO Laboratories Ltd. and distributed by LEO Pharma Inc. The label features red and black text on a white background with the Enstilar logo and LEO Pharma trademark.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
